AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 71 min read$ARQQ

Willcocks Patrick sold $14K of ARQQ

Willcocks Patrick (General Counsel) sold 588 shares of Arqit Quantum Inc. (ARQQ) at $23.78 on 2026-10-05.

Original reporting
SEC EDGAR · Willcocks Patrick
Published Oct 7, 2026, 11:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 11:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The sale is routine and unlikely to affect ARQQ's price materially.

02

Market read

Routine insider sale with minimal market relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in this filing.

Relevance 3/10Novelty 3/10Timing: post-market filing

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$ARQQNeutralHigh confidence
Context

General Counsel sold 588 shares for $13,985, reducing holdings to 11,764 shares.

Expected impact

likely negligible pressure as the market prices the modest sell-off

Evidence & confidence

The transaction size is under $15k, typical for routine insider sales and unlikely to move the stock.

Market effects

Sector

minimal effect on the quantum technology sector

Regional

none

Global

none

Counterpoint

What could challenge this read

Even small insider sales can signal confidence issues, but this size is too trivial to infer sentiment.

Key entities

  • person
    Willcocks Patrick

    General Counsel of Arqit Quantum Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARQQ insider trading history →

Related articles

JUN 4
$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

finance.yahoo.com4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min